These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25698468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Ranade R, Kand P, Basu S.
    Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373
    [Abstract] [Full Text] [Related]

  • 6. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hung MC, Wu HS, Kao CH, Chen WK, Changlai SP.
    Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 9. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 10. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, Berdelou A, Lepoutre-Lussey C, Mirghani H, Baudin E, Schlumberger M, Leboulleux S.
    Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
    [Abstract] [Full Text] [Related]

  • 11. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
    Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Choe JH, Kim JH, Kim JS.
    Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
    Dahele M, Ung YC, Ehrlich L, Silverberg J, Balogh J, Wong CS.
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
    [Abstract] [Full Text] [Related]

  • 14. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
    Ong SC, Ng DC, Sundram FX.
    Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
    Trybek T, Kowalska A, Lesiak J, Młynarczyk J.
    Nucl Med Rev Cent East Eur; 2014 Jun; 17(2):87-93. PubMed ID: 25088108
    [Abstract] [Full Text] [Related]

  • 18. Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.
    Yurkiewicz IR, Ganjoo KN, Iagaru A.
    Clin Nucl Med; 2018 Apr; 43(4):e113-e114. PubMed ID: 29356736
    [Abstract] [Full Text] [Related]

  • 19. [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan].
    Sanz Viedma S, Borrego Dorado I, Rodríguez Rodríguez JR, Navarro González E, Vázquez Albertino R, Fernández López R, Agudo Martínez A.
    Rev Esp Med Nucl; 2011 Apr; 30(2):77-82. PubMed ID: 21334773
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.